Clinical Trial

First-in-Human Trial of Oral AN2-502998

Name: First-in-Human Trial of Oral AN2-502998 — clinical trial record (NCT07024589)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

First-in-Human Phase 1, Single-Center, Randomized, Blinded, Placebo-Controlled Trial in Healthy Adults to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Oral AN2-502998

Protocol Amendment History 1 change

critical Trial completed 2026-05-01

Trial Details

NCT Number	NCT07024589
Lead Sponsor	AN2 Therapeutics, Inc
Conditions	Healthy Volunteers
Enrollment	72 participants
Start Date	2025-08-04
Primary Completion	2026-03-14 (estimated)
Study Completion	2026-03-14 (estimated)
Updated on ClinicalTrials.gov	2026-04-30